Drug Type Small molecule drug |
Synonyms Compound Deserpidine, Deserpidine Compound, 地舍平/甲氧噻嗪 + [3] |
Target |
Action inhibitors |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (01 Aug 1961), |
Regulation- |
Molecular FormulaC9H11Cl2N3O4S2 |
InChIKeyCESYKOGBSMNBPD-UHFFFAOYSA-N |
CAS Registry135-07-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Hypertension | United States | 01 Aug 1961 |





